scholarly journals Confirmatory Results about Spironolactone (S) Effects on AASI in Essential Hypertensive Patients: Short Communication

Author(s):  
Mario Bendersky ◽  
Mario Bendersky

In this short communication we report complementary data to previous ones, which confirm the effects of spironolactone in reducing AASI, a marker of arterial stiffness, in essential hypertensive patients after 6 months of treatment.

2021 ◽  
Vol 8 (3) ◽  
pp. 01-02
Author(s):  
Mario Bendersky

Background: In previous studies we demonstrated that spironolactone 50 mg OD, added in hypertensive patients who do not normalize pressure with enalapril 10 mg in the morning, after 3 months reduces pressure and reduces arterial stiffness.


2005 ◽  
Vol 12 (3) ◽  
pp. 183
Author(s):  
Y. Plantinga ◽  
L. Ghiadoni ◽  
A. Magagna ◽  
M. Bernardini ◽  
S. Taddei ◽  
...  

2018 ◽  
Vol 24 (C) ◽  
pp. 103
Author(s):  
Areti Triantafyllou ◽  
Konstantina Dipla ◽  
Nikolaos Koletsos ◽  
Alexandros-Savvas Zafeiridis ◽  
Stauros Papadopoulos ◽  
...  

2011 ◽  
Vol 5 (4) ◽  
pp. 147
Author(s):  
M.L. Muiesan ◽  
D. Rizzoni ◽  
M. Salvetti ◽  
A. Paini ◽  
C. Agabiti Rosei ◽  
...  

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Yu-Chi Chang ◽  
Bang-Gee Hsu ◽  
Hung-Hsiang Liou ◽  
Chung-Jen Lee ◽  
Ji-Hung Wang

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Manuel A Gomez-Marcos ◽  
Jose I Recio-Rodríguez ◽  
Maria C Patino-Alonso ◽  
Cristina Agudo-Conde ◽  
Leticia Gomez-Sanchez ◽  
...  

2021 ◽  
Vol 39 (Supplement 1) ◽  
pp. e114-e115
Author(s):  
João Marcos De M Zanatta ◽  
Fábio Dos S Ricardi ◽  
Tatiana De A Rubio ◽  
Elizabeth E S Cestário ◽  
Luciana N Cosenso-Martin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document